Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/16/2001 | US20010014332 Modified immunogenic pneumolysin compositions as vaccines |
08/16/2001 | US20010014328 A multispecific binding molecule, comprising a first binding determinant which binds an Fc alpha receptor is not blocked by human immunoglobin A and a second binding determinant binds target cancer cell antigen |
08/16/2001 | US20010014327 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response |
08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
08/16/2001 | US20010014319 Defective recombinant virus containing at least one inserted gene encoding all or part of lecithin-cholesterol acyltransferase (LCAT) or a variant thereof; treating or preventing dyslipoproteinaemia-related diseases |
08/16/2001 | US20010013298 Capillary printing systems |
08/16/2001 | US20010013295 Capillary printing systems |
08/16/2001 | EP1144678A3 Susceptibility to psoriasis |
08/16/2001 | EP1144661A3 Method of genetic modification of a wild type viral sequence |
08/16/2001 | EP1144627A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
08/16/2001 | EP1124198A1 A biological molecule based computing method based on a blocking principle |
08/16/2001 | EP1124128A2 Automated optical reader for nucleic acid assays |
08/16/2001 | EP1123980A2 System for simple nucleic acid analysis |
08/16/2001 | EP1123979A1 Process for producing coenzyme q 10? |
08/16/2001 | EP1123978A1 A cytochrome P450 gene highly expressed in the incompatible interaction |
08/16/2001 | EP1123977A1 GENES ENCODING PROTEINS REGULATING pH OF VACUOLES |
08/16/2001 | EP1123976A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
08/16/2001 | EP1123974A1 Endoglucanases and cellulase preparations containing the same |
08/16/2001 | EP1123509A2 Methods of diagnosing or prognosing alzheimer's disease |
08/16/2001 | EP1123417A2 Method for the exponential amplification of molecular matrices |
08/16/2001 | EP1123414A1 Antisense modulation of integrin alpha 4 expression |
08/16/2001 | EP1123413A1 Multiple sequencing method |
08/16/2001 | EP1123407A2 Apomixis conferred by expression of serk interacting proteins |
08/16/2001 | EP1123406A1 cDNA SEQUENCE TRANSCRIBING A mRNA CODING FOR THE TERMINAL OXYDASE ASSOCIATED WITH CAROTENOID BIOSYNTHESIS AND USES |
08/16/2001 | EP1123405A1 Materials and methods involving conditional aggregation domains |
08/16/2001 | EP1123404A2 Materials and methods for the modification of plant cell wall polysaccharides |
08/16/2001 | EP1123403A1 OMP85 PROTEINS OF $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS), COMPOSITIONS CONTAINING SAME AND METHODS OF USE THEREOF |
08/16/2001 | EP1123402A2 Nucleic acids that control reproductive development in plants |
08/16/2001 | EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
08/16/2001 | EP1123400A1 Gene for a thrombin inhibitor from the triatoma genus and protein with a thrombin-inhibiting effect |
08/16/2001 | EP1123399A2 Production and use of modified cystatins |
08/16/2001 | EP1123398A2 Molecular pathogenicide mediated plant disease resistance |
08/16/2001 | EP1123397A2 G-protein coupled receptors |
08/16/2001 | EP1123396A2 Minimal promoters and uses thereof |
08/16/2001 | EP1123395A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
08/16/2001 | EP1123394A2 Proliferation and apoptosis related proteins |
08/16/2001 | EP1123393A1 Follistatin-related protein zfsta2 |
08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
08/16/2001 | EP1123391A2 Methods for improving the function of heterologous g protein-coupled receptors |
08/16/2001 | EP1123390A2 Methods and reagents for isolating biologically active peptides |
08/16/2001 | EP1123389A1 A method of affinity separation and ligands for use therein |
08/16/2001 | EP1123388A1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
08/16/2001 | EP1123387A2 Mn gene and protein |
08/16/2001 | EP1123386A1 Method for producing chiral carboxylic acids from nitriles with the assistance of a nitrilase or microorganisms which contain a gene for the nitrilase |
08/16/2001 | EP1123385A2 Human proteins involved in endoplasmic reticulum protein degradation |
08/16/2001 | EP1123383A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
08/16/2001 | EP1123315A1 Multiple domain glycoprotein hormones and methods of using |
08/16/2001 | EP1123313A2 Methods and compositions for the prevention and treatment of anemia |
08/16/2001 | EP1123312A2 Human rna binding proteins |
08/16/2001 | EP1123311A1 Isolated proteins and nucleic acid molecules having homology to the nip2 protein and uses thereof |
08/16/2001 | EP1123310A1 Gene cluster involved in nogalamycin biosynthesis, and its use in production of hybrid antibiotics |
08/16/2001 | EP1123306A1 Inhibitors of platelet activation and recruitment |
08/16/2001 | EP1123305A1 Dna-templated combinatorial library chemistry |
08/16/2001 | EP1123160A1 Device for conducting biochemical and microbiological reactions |
08/16/2001 | EP1123158A1 Adsorbent medium and its use in purifying dna |
08/16/2001 | EP1123113A1 Ribozymes used as prodrugs |
08/16/2001 | EP1123111A1 Modulation of gene expression by combination therapy |
08/16/2001 | EP1123109A1 Contulakin-g, analogs thereof and uses therefor |
08/16/2001 | EP1123108A1 Isolated peptides which bind to hla-b35 molecules |
08/16/2001 | EP1123004A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
08/16/2001 | EP1004056A4 Multi parameter scanner |
08/16/2001 | EP0937097B1 Compositions and methods for immobilizing nucleic acids to solid supports |
08/16/2001 | EP0929693B1 Multiplex polynucleotide capture methods and compositions |
08/16/2001 | EP0891369B1 Process and device for isolating nucleic acids |
08/16/2001 | EP0827547B1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof |
08/16/2001 | EP0820523A4 Conserved yeast nucleic acid sequences |
08/16/2001 | EP0805877B1 Improved method of selecting specific bacteriophages |
08/16/2001 | EP0784702A4 Diagnostic test using fc receptor |
08/16/2001 | EP0777750A4 High throughput screening method for sequences or genetic alterations in nucleic acids |
08/16/2001 | EP0759944B1 Target cell binding chimaeric peptides |
08/16/2001 | EP0749444B1 Hybrid human/animal factor viii |
08/16/2001 | EP0731843B1 Tyrosinase-activator protein fusion enzyme |
08/16/2001 | EP0698097B1 Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae |
08/16/2001 | EP0668932B1 Positional sequencing by hybridization |
08/16/2001 | EP0647278B1 Method and system for molecular-biological diagnostics |
08/16/2001 | EP0576483B1 Biocidal proteins |
08/16/2001 | DE10064343A1 Nukleinsäure für die Untersuchung des proteasomalen Proteinabbaus Nucleic acid for the investigation of the proteasomal protein degradation |
08/16/2001 | DE10045182A1 Verwendung von Palatinase- und Trehalulase-Sequenzen als nutritive Marker in transformierten Zellen Use of palatinase and trehalulase sequences as nutritional markers in transformed cells |
08/16/2001 | DE10045113A1 Verfahren zur Beeinflussung der Pollenentwicklung durch Veränderung des Saccharosestoffwechsels Method for influencing the pollen development by varying the sucrose metabolism |
08/16/2001 | DE10006214A1 System zur einfachen Nukleinsäureanalytik System for easy analysis of nucleic acids |
08/16/2001 | DE10006201A1 New genes involved in oxidation of reduced sulfur compounds, particularly conversion of thiosulfate to sulfate, and related proteins, from Paracoccus pantotrophus |
08/16/2001 | DE10005973A1 Neues Elongasegen und Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren New elongase gene and methods for the production of polyunsaturated fatty acids |
08/16/2001 | DE10004857A1 MLP-Gen, Nukleinsäuren, Polypeptide und deren Verwendung MLP-gene nucleic acids, polypeptides and their use |
08/16/2001 | DE10002446A1 Genchip für ein Neugeborenen Screening Gene chip for a newborn screening |
08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
08/16/2001 | CA2412143A1 Transgenic cells expressing glucosyltransferase nucleic acids |
08/16/2001 | CA2400802A1 Compositions and methods for screening therapeutic agents |
08/16/2001 | CA2400583A1 Porcine reproductive and respiratory syndrome virus and methods of use |
08/16/2001 | CA2400509A1 Regulated expression of plac in staphylococcus aureus |
08/16/2001 | CA2400497A1 Methods and compositions for generating angiostatin |
08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
08/16/2001 | CA2400187A1 Protein c derivatives |
08/16/2001 | CA2399945A1 Larynx carcinoma-associated protein larcap-1 |
08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
08/16/2001 | CA2399876A1 Human proteases and polynucleotides encoding the same |
08/16/2001 | CA2399874A1 Enzyme-based gprotein-coupled receptor assay |
08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
08/16/2001 | CA2399839A1 Protein design automation for protein libraries |
08/16/2001 | CA2399769A1 Inhibitors of apoptosis |